Capillary technologies India Limited has announced a comprehensive schedule of analyst and investor meetings set to take place in Mumbai from February 11-13, 2026. The company disclosed this information on February 06, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Schedule Details

The company has organized multiple one-on-one and group meetings across three consecutive days, all to be conducted in physical mode in Mumbai. The structured approach demonstrates the company's commitment to maintaining regular communication with its investor community.

Regulatory Compliance and Guidelines

The company has issued important disclaimers regarding the scheduled meetings. The schedule may undergo changes due to exigencies on the part of participants or the company itself. More significantly, Capillary Technologies has explicitly stated that no Unpublished Price Sensitive Information (UPSI) is intended to be discussed during these interactions, ensuring compliance with regulatory requirements.

Communication and Transparency

In line with transparency practices, the company has made this intimation available on its official website. Investors and stakeholders can access detailed information through the company's investor relations section. The disclosure was signed by Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, demonstrating proper corporate governance protocols.

Company Information

Capillary Technologies India Limited operates under CIN L72200KA2012PLC063060, with its registered office located in Bengaluru, Karnataka. The company maintains active communication channels through its dedicated investor relations portal and official website, reinforcing its commitment to stakeholder engagement and regulatory compliance.

Capillary technologies India Limited has announced the schedule for its third quarter FY26 earnings conference call, set to take place on February 6, 2026. The AI-based cloud-native Software-as-a-Service provider will discuss its financial performance for the quarter ended December 31, 2025.

Conference Call Schedule

The earnings conference call has been scheduled following regulatory requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company filed the intimation on February 2, 2026, notifying both BSE Limited and National Stock Exchange of India Limited about the upcoming earnings call.

Management Participation

The earnings conference call will feature senior management representatives who will discuss the company's quarterly performance and address investor queries. The management team participating in the call includes key executives from various operational areas.

Registration and Access

Investors and analysts interested in participating in the earnings call can register through the company's official website. The registration link directs participants to the investor relations section at the company's finances and reports page. Post-registration, participants will receive an email containing detailed call information and access credentials.

The company has also announced that both transcript and audio recording of the earnings conference call will be made available on its website following the session. This ensures broader accessibility for stakeholders who may not be able to participate in the live call.

Company Profile

Capillary Technologies India Limited operates as a software product company specializing in artificial intelligence-based cloud-native SaaS products and solutions. The company primarily serves Enterprise Customers globally, defined as customers contributing ₹ 8.00 million in revenue from operations in a fiscal year. The company's solutions focus on developing loyalty programs for consumers and channel partners of its enterprise clients.

The company is registered with CIN L72200KA2012PLC063060 and maintains its registered office in Bengaluru, Karnataka. For investor relations queries, stakeholders can reach out to the designated contact persons including Sunil M Jain and the investor relations team at E&Y LLP.